Table 1.
Sample Characteristics Before and After Matching for 2018
| |
2018 Before matching |
2018 After matching |
||||||
|---|---|---|---|---|---|---|---|---|
| |
WMHP users group |
Comparison group |
|
|
WMHP users group |
Comparison group |
|
s |
| Variable | n = 2990 |
n = 40,027 |
Standardized differences | P | n = 2791 |
n = 2791 |
Standardized differences | P |
| Mean or % | Mean or % | Mean or % | Mean or % | |||||
| Age | 31.08 | 27.29 | 0.311 | <0.001 | 30.81 | 31.44 | −0.078 | 0.004 |
| Adult (%) | 92.8% | 67.9% | 0.659 | <0.001 | 92.8% | 89.8% | 0.104 | <0.001 |
| Female (%) | 52.7% | 42.6% | 0.203 | <0.001 | 52.6% | 50.6% | 0.040 | 0.141 |
| MSA 1 | 31.3% | 25.8% | 0.122 | <0.001 | 31.9% | 29.6% | 0.051 | 0.056 |
| MSA 2 | 15.2% | 15.9% | −0.018 | 0.334 | 15.4% | 17.1% | −0.045 | 0.095 |
| MSA 3 | 12.0% | 9.0% | 0.096 | <0.001 | 11.7% | 12.4% | −0.021 | 0.434 |
| MSA 4 | 5.0% | 2.9% | 0.110 | <0.001 | 5.1% | 4.9% | 0.008 | 0.758 |
| MSA 5 | 5.2% | 2.6% | 0.130 | <0.001 | 4.8% | 3.7% | 0.059 | 0.028 |
| All other MSAs | 31.3% | 43.7% | −0.259 | <0.001 | 31.1% | 32.5% | −0.030 | 0.262 |
| Mood disorders (%) | 36.6% | 3.1% | 0.927 | <0.001 | 36.0% | 36.0% | 0.000 | 1.000 |
| Anxiety (%) | 64.2% | 4.0% | 1.646 | <0.001 | 64.3% | 54.2% | 0.208 | <0.001 |
| Adjustment disorders (%) | 42.3% | 1.9% | 1.115 | <0.001 | 42.5% | 24.3% | 0.394 | <0.001 |
| Attention-deficit disorders (%) | 5.0% | 1.7% | 0.182 | <0.001 | 4.7% | 4.7% | 0.000 | 1.000 |
| Alcohol/substance disorders (%) | 2.1% | 0.5% | 0.144 | <0.001 | 1.5% | 1.5% | 0.000 | 1.000 |
| Asthma(%) | 2.7% | 2.4% | 0.019 | 0.345 | 2.1% | 2.1% | 0.000 | 1.000 |
| Blood cell disease (%) | 0.4% | 0.3% | 0.019 | 0.365 | 0.1% | 0.1% | 0.000 | 1.000 |
| Cancer (%) | 0.7% | 0.5% | 0.016 | 0.438 | 0.1% | 0.1% | 0.000 | 1.000 |
| Secondary cancer (%) | 0.0% | 0.1% | −0.035 | 0.330 | 0.0% | 0.0% | 0.000 | 1.000 |
| Cardiovascular (%) | 2.8% | 2.6% | 0.012 | 0.545 | 1.7% | 1.7% | 0.000 | 1.000 |
| Lower back/disk diseases (%) | 16.9% | 8.4% | 0.257 | <0.001 | 14.7% | 14.7% | 0.000 | 1.000 |
| Diabetes (%) | 0.7% | 0.9% | −0.021 | 0.352 | 0.5% | 0.5% | 0.000 | 1.000 |
| Diabetes with complications (%) | 0.8% | 0.8% | 0.002 | 1.000 | 0.4% | 0.4% | 0.000 | 1.000 |
| Esophageal/upper GI diseases (%) | 2.2% | 1.4% | 0.055 | 0.002 | 1.2% | 1.2% | 0.000 | 1.000 |
| Hypertension (%) | 1.6% | 1.8% | −0.009 | 0.681 | 1.5% | 1.2% | 0.028 | 0.352 |
| Metabolic disorders (%) | 2.8% | 2.4% | 0.023 | 0.230 | 1.7% | 1.7% | 0.000 | 1.000 |
| Migraine/headache (%) | 4.8% | 2.5% | 0.128 | <0.001 | 3.6% | 3.6% | 0.000 | 1.000 |
| Multiple sclerosis (%) | 0.1% | 0.1% | 0.006 | 1.000 | 0.0% | 0.0% | 0.000 | 1.000 |
| Neurological disorders (%) | 4.4% | 2.9% | 0.078 | <0.001 | 2.8% | 2.8% | 0.000 | 1.000 |
| Osteoarthritis (%) | 0.7% | 0.6% | 0.014 | 0.500 | 0.1% | 0.1% | 0.000 | 1.000 |
| Pregnancy and labor (%) | 3.4% | 3.0% | 0.020 | 0.301 | 3.1% | 3.1% | 0.000 | 1.000 |
| Rheumatoid arthritis (%) | 0.3% | 0.2% | 0.012 | 0.628 | 0.1% | 0.1% | 0.000 | 1.000 |
GI, gastrointestinal; MSA, metropolitan statistical area; WMHP, workforce mental health program.